Source check ·
CoreAge Rx NAD+ Sale: Complete the Price Comparison Questions
Compare CoreAge Rx’s $93 starting listing and $99 NAD+ Fall Sale by asking about the preparation, full supply cost, renewal and availability.
Comparison needs complete terms
CoreAge Rx’s NAD+ Injectable listing starts at $93/month, while the separate Fall Sale page advertises $99/month. The November 8, 2026 check did not establish matching commitments behind them.
Promotional publication supporting CoreAge Rx, part of a commonly owned network. This guide reviews published terms; it is not an independent medical review or a tested checkout. Ownership & disclosure.
Do both amounts buy the same arrangement?
The sources do not establish that. The ordinary page gives a starting figure, while the offer page places $99 beside a $199 comparison and describes multi-month options. Keep each number attributed to its page. Do not call the sale cheaper than the ordinary listing or use its reference amount as a verified usual price.
Sources: CoreAge Rx: NAD+ Injectable starting-price page · CoreAge Rx: NAD+ Fall Sale details
How much must be paid for the selected supply?
The offer describes upfront payment for 3-, 6- and 12-month options but does not publish their full prices here. Request the actual chosen total instead of multiplying either headline. General payment alternatives, including installment providers, do not establish the final amount, fees or financing eligibility for a specific NAD+ order.
Sources: CoreAge Rx: NAD+ Fall Sale details · CoreAge Rx: Purchase plans and payment options
What triggers the next charge?
The offer page describes another payment when another order is placed. General guidance also supports optional subscriptions. Ask which option is selected and what date and amount would follow. A multi-month plan does not, by itself, answer whether renewal is automatic, and stopping future renewal is distinct from reversing a processed order.
Sources: CoreAge Rx: NAD+ Fall Sale details · CoreAge Rx: Purchase plans and payment options · CoreAge Rx: Refund and subscription conditions
Does the page prove the treatment is available to me?
No Coming soon wording was found, but stock, prescribing and fulfillment were not tested. Eligibility requires clinical assessment in supported service areas. Compounded medicines are not FDA-approved. Even a clarified commercial quote cannot determine whether the proposed preparation is suitable for an individual.
Sources: CoreAge Rx: NAD+ Injectable starting-price page · CoreAge Rx: NAD+ Fall Sale details · FDA: Compounding and FDA approval
Questions about this guide
Does the savings badge settle the comparison?
No. Its percentage does not reconcile with the displayed $199-to-$99 figures, and the underlying comparison basis remains unverified.
Which fields make a quote useful?
The exact preparation, supply period, complete charge, payment schedule and renewal arrangement should be stated together, with unresolved conditions clearly identified.
Sources checked for this guide
Public pages checked November 8, 2026. Prices and terms may change; no purchase, medical intake or redemption was tested.